ShareHope Medicine Co Ltd (8403) — Capital Reinvestment Ratio
ShareHope Medicine Co Ltd (8403) has a Capital Reinvestment Ratio of 0.35x as of December 2025, meaning it reinvests 0% of its operating cash flow (NT$113.37 Million) in capital expenditures (NT$39.14 Million). Check tangible equity quality of ShareHope Medicine Co Ltd to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
ShareHope Medicine Co Ltd Capital Reinvestment Ratio (2017–2025)
This chart tracks ShareHope Medicine Co Ltd's Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see cash flow conversion of ShareHope Medicine Co Ltd.
Annual Capital Reinvestment Ratio for ShareHope Medicine Co Ltd (2017–2025)
Year-by-year Capital Reinvestment Ratio for ShareHope Medicine Co Ltd from 2017 to 2025. See 8403 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.36x | NT$364.12 Million | NT$131.81 Million | ▲ +3.8% |
| 2024 | 0.35x | NT$266.68 Million | NT$93.02 Million | ▼ -67.6% |
| 2023 | 1.08x | NT$257.13 Million | NT$277.20 Million | ▼ -46.1% |
| 2022 | 2.00x | NT$642.47 Million | NT$1.28 Billion | ▲ +372.7% |
| 2021 | 0.42x | NT$360.10 Million | NT$152.26 Million | ▼ -16.6% |
| 2020 | 0.51x | NT$717.74 Million | NT$364.00 Million | ▲ +144.7% |
| 2019 | 0.21x | NT$502.62 Million | NT$104.17 Million | ▼ -93.1% |
| 2018 | 3.02x | NT$33.91 Million | NT$102.27 Million | ▲ +6.4% |
| 2017 | 2.83x | NT$62.76 Million | NT$177.91 Million | — |